Natives are getting restless here@Davisite . Other biotechs jump by 20% a day and we are left twiddling our thumbs waiting for our management to release another revised strategy for us to get onboard with.
As much as @johndprent is hoping for a licensing agreement for AML , I think based on what you have said before , its clearly not going to happen.You have previously said taking on any agreements at this early stage is not beneficial for shareholders .
Which means that we are looking at running trials for another year at least and finding a way to fund them ourselves.
Ann: RC220 Meets Quality Specifications, page-56
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
0.085(5.80%) |
Mkt cap ! $264.2M | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.55 | $1.49 | $246.4K | 163.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.55 | 5483 | 2 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |